M&A opportunities hero

    Live Deal Pipeline

    Deal detail

    Browse Samjong KPMG's control sale, investment, and real-estate opportunities in one place.

    Healthcare & BiotechPublished deal

    Project Versace - Financing

    Korea's only pipeline in the radiosensitizer market for enhancing the efficacy of cancer radiotherapy

    Location
    Korea
    Industry
    Healthcare & Biotech
    RevenueContact us
    AskingKRW 47.5 billion pre-money valuation
    Deal structureKRW 5 billion capital raise (negotiable)
    FinancialsContact us

    Investment highlights

    • Lead pipeline achieved a 100% complete-response rate in Phase 1 and is progressing well through a U.S. FDA Phase 2 trial
    • Advanced discussions under way with global pharmaceutical companies and regional partners regarding licensing-out transactions
    • Of the KRW 8 billion target raise, KRW 3 billion has been committed; the remaining KRW 5 billion will support a global licensing transaction and achievement of clinical milestones

    Deal partner

    Euijin Kim, Manager
    문의